PHARVARIS N.V. EO -12 (9EN F) stock market data APIs

€17.71 0.51(3%)
as of February 10, 2025

PHARVARIS N.V. EO -12 Financial Data Overview

Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks which is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients which is under Phase 1 clinical trial. The company operates in the Netherlands, Switzerland, and the United States. Pharvaris N.V. was incorporated in 2015 and is based in Leiden, the Netherlands.

Prev. Close 17.37
Open 17.71
High 18.24
Low 16.96
52 wk Range 13.7-26.2
Market Cap 969 M
Shares Outstanding 54 233 K
Revenue 0
EPS -1.1
Beta -3.145

Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get PHARVARIS N.V. EO -12 data using free add-ons & libraries


Get PHARVARIS N.V. EO -12 Fundamental Data

PHARVARIS N.V. EO -12 Fundamental data includes:

  • Net Revenue: 0
  • EBITDA: -116 103 928
  • Earnings Per Share: -2
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get PHARVARIS N.V. EO -12 Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2021-06-30
  • EPS/Forecast: -0.5
GET THE PACKAGE

Get PHARVARIS N.V. EO -12 End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

PHARVARIS N.V. EO -12 News

Get Apple Inc fresh news feed via Financial News API

Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat